Precision Molecular Pathology of Hodgkin Lymphoma (eBook, PDF)

Redaktion: Hudnall, S. David; Küppers, Ralf

• Format: PDF

Produktbeschreibung

This text provides a comprehensive and up-to-date overview of Hodgkin lymphoma. The volume reviews every facet of the cancer in great detail, including pathology, pathobiology, molecular genetics, microenvironment, epidemiology, treatment, and new therapeutic advances. The specific role of the lymphoma microenvironment is addressed, and the relationship of Hodgkin lymphoma to related non-Hodgkin lymphomas is covered as well.

Written by experts in the field, Precision Molecular Pathology of Hodgkin Lymphoma is a valuable resource for oncologists, surgeons, pathologists, clinical trainees, and investigators engaged in the diagnosis, treatment, and research studies of this lymphoid neoplasm.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Springer Nature Switzerland
• Seitenzahl: 236
• Erscheinungstermin: 9. Dezember 2017
• Englisch
• ISBN-13: 9783319680941
• Artikelnr.: 56821910

Autorenporträt

S. David Hudnall, MD Professor of Pathology and Laboratory Medicine Director, Hematopathology Program Associate Medical Director, Precipio Diagnostics, LLC Yale University School of Medicine 310 Cedar Street New Haven, CT 06520 USA Dr. Ralf Küppers University of Duisburg-Essen Department of Molecular Genetics Institute of Cell Biology Hufelandstr. 55 45122 Essen Germany 

Inhaltsangabe

Introduction.- Clinical features.- Histopathology of Hodgkin lymphoma and closely related lymphomas.- Pathogenesis and molecular genetics of classical Hodgkin lymphoma.- The microenvironment in classical Hodgkin lymphoma.- Role of EBV in classical Hodgkin lymphoma.- Pathobiology of nodular lymphocyte predominant Hodgkin lymphoma.- Composite lymphomas and the relationship of Hodgkin lymphoma to Non-Hodgkin lymphomas.- Epidemiology and genetic risk factors.- Treatment and Prognosis.- Development of targeted therapies.